SCHEDULE: Vanguard Discloses 7.35% Stake in The Clorox Company
Schedule 13G
Vanguard Capital Management has filed a Schedule 13G reporting a 7.35% beneficial ownership stake in The Clorox Company.
Summary
- Vanguard Capital Management reported beneficial ownership of 8,889,552 shares of The Clorox Company common stock.
- This holding represents 7.35% of the total outstanding class of securities.
- The filing indicates that Vanguard maintains sole dispositive power over all 8,889,552 shares.
- Vanguard holds sole voting power over 1,039,115 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure confirming institutional interest without signaling strategic shifts.
Positives
- Institutional confidence demonstrated by a significant 7.35% ownership stake from a major investment manager.
- The acquisition is confirmed to be in the ordinary course of business, indicating a passive investment strategy.
Negatives
- NA
Risks
- Market volatility affecting the value of the 8.89 million shares held.
- Potential for future divestment by the institutional holder impacting share price liquidity.
Future Outlook
The filing states the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Management Comments
- Vanguard certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that institutional filings like this are standard disclosures for large asset managers and generally reflect long-term portfolio positioning rather than activist intent.
Comparison to Industry Standards
- Vanguard's position is consistent with its role as a major index and active fund manager holding significant stakes in S&P 500 constituents.
- The 7.35% stake is typical for large-cap consumer goods companies where institutional ownership is highly concentrated.
Legal Proceedings
- None mentioned.
Related Party Transactions
- None mentioned.
Stakeholder Impact
- Shareholders may view the stable, long-term institutional holding as a sign of confidence in the company's market position.
Next Steps
- Continued monitoring of institutional ownership changes in future 13F or 13G filings.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of event which requires filing of this statement. |
| 04/29/2026 | Date of signature and filing of the Schedule 13G. |
Keywords
Clorox, Vanguard, Schedule 13G, Institutional Ownership, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.